题名 | Erratum: Overcome trastuzumab resistance of breast cancer using anti-HER2 chimeric antigen receptor T cells and PD1 blockade. |
作者 | |
发表日期 | 2022-06-15 |
发表期刊 | American journal of cancer research 影响因子和分区 |
语种 | 英语 |
原始文献类型 | Published Erratum |
摘要 | [This corrects the article on p. 688 in vol. 10, PMID: 32195036.]. |
ISSN | 2156-6976 |
卷号 | 12期号:6页码:2891-2892 |
收录类别 | PUBMED |
URL | 查看原文 |
Pubmed记录号 | 35812051 |
文献类型 | 期刊论文 |
条目标识符 | https://kms.wmu.edu.cn/handle/3ETUA0LF/155330 |
专题 | 检验医学院(生命科学学院、生物学实验教学中心) 附属第一医院 其他_附属第三医院(瑞安市人民医院) |
作者单位 | 1.Key Laboratory of Laboratory Medicine, Ministry of Education, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University Wenzhou 325035, Zhejiang, China.; 2.Department of Clinical Laboratory, The Children's Hospital, Zhejiang University School of Medicine Hangzhou 310052, Zhejiang, China.; 3.Department of Orthopedics, Third Affiliated Hospital of Wenzhou Medical University Wenzhou 325200, Zhejiang, China.; 4.Department of Pathology, First Affiliated Hospital of Wenzhou Medical University Wenzhou 325035, Zhejiang, China. |
第一作者单位 | 检验医学院(生命科学学院、生物学实验教学中心) |
第一作者的第一单位 | 检验医学院(生命科学学院、生物学实验教学中心) |
推荐引用方式 GB/T 7714 | Li, Hongzhi,Yuan, Weihua,Bin, Shufang,et al. Erratum: Overcome trastuzumab resistance of breast cancer using anti-HER2 chimeric antigen receptor T cells and PD1 blockade.[J]. American journal of cancer research,2022,12(6):2891-2892. |
APA | Li, Hongzhi., Yuan, Weihua., Bin, Shufang., Wu, Guang., Li, Panyuan., ... & Gu, Haihua. (2022). Erratum: Overcome trastuzumab resistance of breast cancer using anti-HER2 chimeric antigen receptor T cells and PD1 blockade.. American journal of cancer research, 12(6), 2891-2892. |
MLA | Li, Hongzhi,et al."Erratum: Overcome trastuzumab resistance of breast cancer using anti-HER2 chimeric antigen receptor T cells and PD1 blockade.".American journal of cancer research 12.6(2022):2891-2892. |
条目包含的文件 | 条目无相关文件。 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论